Close Menu
    Subscribe
    Advertisement

    Events Search and Views Navigation

    Event Views Navigation

    Today

    CANCELLED: Decennial 2020 – International Conference on Healthcare Associated Infections

    Atlanta Marriott Marquis 265 Peachtree Center Ave NE, Atlanta, GA, United States

    Notice from organizers 17 March 2020 After much deliberation and consideration of the Decennial participants’ substantial role in addressing COVID-19 globally, the Society for Healthcare Epidemiology of America’s Board of Trustees unanimously decided the 6th Decennial International Conference on Healthcare Associated Infections will no longer occur March 26 – 30, 2020, in Atlanta, GA. Centers

    APIC AIHA Webinar – Ventilation, Surface Disinfection and PPE Considerations for the IP and IH

    Webinar

    Amidst the flood of information about the COVID-19 pandemic, one of the greatest risks is missing key intelligence that can protect health and save lives. This town hall-style webinar, co-hosted by AIHA and the Association for Professionals in Infection Control and Epidemiology (APIC), will address occupational health and safety professionals’, industrial hygienists’ and infection preventionists’

    Featured Featured

    SMi’s 22nd Annual Superbugs & Superdrugs – Remote Access Conference

    Holiday Inn Kensington Forum 97 Cromwell Rd, London, United Kingdom

    Due to ongoing concerns over COVID-19 this conference is now available with remote access only SMi’s 22nd Annual Superbugs & Superdrugs 2020 Conference will be held  30-31 March 2020. A Focus on Non-traditional Approaches in the Fight against Antimicrobial Resistance Sponsored by Scynexis CO-CHAIRS FOR 2020: Cara Cassino, Chief Medical Officer, Contrafect & Michael Dawson,

    Proposals Due: Influenza Data Processing and Outreach

    Global Biodefense Calendar

    If your small business has strong experience with scientific data processing and outreach, consider sending a contract proposal to establish an Influenza Data Processing and Communication Center (iDPCC). This solicitation recompetes and renames the current influenza DPCC contract to support NIAID’s Centers of Excellence for Influenza Research and Response (CEIRR) network. Submit your proposal by April

    NASEM Webinar: The Supply Chain and COVID-19

    Virtual-Webcast

    COVID-19 has had a profound impact on supply chains for many different critical products worldwide. The pandemic has created major changes in freight flows and has challenged the ability to deliver both medical supplies and food. The National Academies' Transportation Research Board (TRB) is hosting a webinar on Wednesday, April 8, 2020, from 2:00 to

    Deadline for NIAID BAA Proposals: Development of Radiation/Nuclear Medical Countermeasures

    Global Biodefense Calendar

    Research Area 001: Development of Radiation/Nuclear Medical Countermeasures (MCMs) HHS-NIH-NIAID-BAA2020-1 This research topic call for proposals is part of the 2020 NIAID Omnibus Broad Agency Announcement. It supports the development of safe and effective MCMs to mitigate and/or treat tissue injuries resulting from exposure to ionizing radiation from a radiological or nuclear incident, thereby leading

    Deadline for NIAID BAA Proposals: Therapeutic Products for Biodefense, AMR Infections, and Emerging Infectious Diseases

    Global Biodefense Calendar

    HHS-NIH-NIAID-BAA2020-1 Research Area 004: Development of Therapeutic Products for Biodefense, Anti-Microbial Resistant (AMR) Infections, and Emerging Infectious Diseases Supports development of promising new therapeutics to address infections caused by NIAID Category A, B, and C priority pathogens and select bacterial and fungal infections identified in CDC’s report Antibiotic Resistance Threats in the United States 2019 , including optimization, preclinical

    Deadline for NIAID BAA Proposals: Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases

    Global Biodefense Calendar

    HHS-NIH-NIAID-BAA2020-1 Research Area 003: Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases Supports development of vaccines 1) to address antibiotic resistant gram-negative bacteria focusing on but not limited to Burkholderia spp., Pseudomonas aeruginosa, Francisella tularensis, Yersinia pestis, and E. coli, and 2) for emerging viruses and pandemic preparedness that includes but is not limited to alphaviruses

    Deadline for NIAID BAA Proposals: Advanced Development of Diagnostics for Biothreats and EID

    Global Biodefense Calendar

    HHS-NIH-NIAID-BAA2020-1 Research Area 005: Advanced Development of Diagnostics for Biothreats and Emerging Infectious Diseases Supports advancing the development of novel, rapid sample-to-answer candidate diagnostic products that will address biodefense and pandemic preparedness. Number of Awards/Total Costs: NIAID estimates that one or more awards may be issued for this Research Area for a total cost of up